TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 34044366

Group type: EXPERIMENTAL
Intervention: VL0 (0% velocity loss)
Number of subjects: 64

Group type: EXPERIMENTAL
Intervention: VL10 (10% velocity loss)
Number of subjects: 64

Group type: EXPERIMENTAL
Intervention: VL20 (20% velocity loss)
Number of subjects: 64

Group type: EXPERIMENTAL
Intervention: VL40 (40% velocity loss)
Number of subjects: 64
Study: 35121639

Group type: EXPERIMENTAL
Intervention: upadacitinib 15 mg
Number of subjects: 500

Group type: COMPARATOR
Intervention: adalimumab 40 mg
Number of subjects: 500

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 500
Study: 33422811

Group type: EXPERIMENTAL
Intervention: Metformin users
Number of subjects: 4328

Group type: COMPARATOR
Intervention: Non-metformin users
Number of subjects: 4328
Study: 32936087

Group type: EXPERIMENTAL
Intervention: Breast Cancer e-Support (BCS) program
Number of subjects: 57
Study: 34133211

Group type: EXPERIMENTAL
Intervention: Neoadjuvant docetaxel, oxaliplatin, and S-1 (DOS) followed by surgery and adjuvant S-1 (CSC group)
Number of subjects: 530

Group type: COMPARATOR
Intervention: Surgery and adjuvant S-1 (SC group)
Number of subjects: 530
Study: 35774405

Group type: EXPERIMENTAL
Intervention: Probiotics
Number of subjects: 70

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 70
Study: 35246565

Group type: EXPERIMENTAL
Intervention: LED‐LLLT (n=20)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Placebo (n=20)
Number of subjects: 40
Study: 32803709

Group type: EXPERIMENTAL
Intervention: Pre-probiotic group (PreProBG, n = 16; 200 g/day yogurt plus 10 g/day inulin+oligofructose)
Number of subjects: 32

Group type: COMPARATOR
Intervention: Probiotic group (ProBG, n = 16; 200 g/day yogurt only)
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Pre-probiotic group (PreProBG)
Number of subjects: 32
Study: 36179982

Group type: EXPERIMENTAL
Intervention: MyPath web-based reproductive health decision support tool
Number of subjects: 456

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 456
Study: 33651675

Group type: EXPERIMENTAL
Intervention: REGN1908-1909
Number of subjects: 73

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 73
Study: 32920614

Group type: COMPARATOR
Intervention: No irrigation after post preparation (G1)
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Distilled water activated for 60 s + distilled water (G2)
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: 5.25% NaOCl 15 s + distilled water (G3)
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: 17% EDTA + 5.25% NaOCl + distilled water (G4)
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: 10% polyacrylic acid + distilled water (G5)
Number of subjects: 50
Study: 36604812

Group type: EXPERIMENTAL
Intervention: ATI-450 50-mg oral tablets twice daily
Number of subjects: 100

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 100
Study: 33495134

Group type: EXPERIMENTAL
Intervention: TEAS (transcutaneous electrical acupoint stimulation)
Number of subjects: 280
Study: 33239067

Group type: EXPERIMENTAL
Intervention: Dulaglutide 1.5 mg
Number of subjects: 9901

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 9901
Study: 35106618

Group type: EXPERIMENTAL
Intervention: Bright day-Dim evening lighting condition (electric bright light 1250 lx during the day and dim light 5 lx during the evening)
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: Dim day-Bright evening lighting condition (dim light during the day and bright light during the evening)
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: Bright day-Dim evening lighting condition
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: Dim day-Bright evening lighting condition
Number of subjects: 14

Group type: COMPARATOR
Intervention: Both lighting protocols
Number of subjects: 14
Study: 34095981

Group type: EXPERIMENTAL
Intervention: Clockwise non‐invasive explantation
Number of subjects: 31

Group type: COMPARATOR
Intervention: Counter‐clockwise non‐invasive explantation
Number of subjects: 31

Group type: EXPERIMENTAL
Intervention: Male patients
Number of subjects: 31

Group type: COMPARATOR
Intervention: Female patients
Number of subjects: 31

Group type: EXPERIMENTAL
Intervention: Overall removal torque
Number of subjects: 31
Study: 33350051

Group type: EXPERIMENTAL
Intervention: Insoles with a toe-grip bar
Number of subjects: 12

Group type: COMPARATOR
Intervention: Regular insoles
Number of subjects: 12
Study: 36041704

Group type: EXPERIMENTAL
Intervention: tcVNS
Number of subjects: 21

Group type: COMPARATOR
Intervention: sham
Number of subjects: 21
Study: 32062050

Group type: EXPERIMENTAL
Intervention: Swaddling + expressed breast milk
Number of subjects: 33

Group type: COMPARATOR
Intervention: Routine care
Number of subjects: 33

Group type: EXPERIMENTAL
Intervention: Swaddling
Number of subjects: 33

Group type: EXPERIMENTAL
Intervention: Facilitated tucking
Number of subjects: 33

Group type: EXPERIMENTAL
Intervention: Expressed breast milk
Number of subjects: 33

Group type: EXPERIMENTAL
Intervention: Facilitated tucking + expressed breast milk
Number of subjects: 33
Study: 35380473

Group type: EXPERIMENTAL
Intervention: Fasted (24 h)
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: Controlled Breathing (CB)
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: Fasted
Number of subjects: 25
Study: 34881361

Group type: EXPERIMENTAL
Intervention: Vitamin D (100,000 IU as a bolus dose followed by 20,000 IU per week)
Number of subjects: 189

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 189
Study: 34844774

Group type: EXPERIMENTAL
Intervention: Intra-operative thoracostomy tube placement (TP)
Number of subjects: 88

Group type: COMPARATOR
Intervention: No thoracostomy tube placement (NTP)
Number of subjects: 88
Study: 33617367

Group type: EXPERIMENTAL
Intervention: ACCESS intervention (two-semester cognitive-behavioral treatment program)
Number of subjects: 250

Group type: COMPARATOR
Intervention: Delayed treatment condition (control)
Number of subjects: 250
Study: 32725848

Group type: EXPERIMENTAL
Intervention: Digital CBT (Daylight)
Number of subjects: 256

Group type: COMPARATOR
Intervention: Waitlist control
Number of subjects: 256
Study: 36163312

Group type: EXPERIMENTAL
Intervention: Restore DCB
Number of subjects: 240

Group type: COMPARATOR
Intervention: SeQuent® Please DCB
Number of subjects: 240
Study: 33640982

Group type: EXPERIMENTAL
Intervention: Cefixime 400 mg orally
Number of subjects: 15
Study: 32798927

Group type: EXPERIMENTAL
Intervention: Music Therapy (MT)
Number of subjects: 37

Group type: COMPARATOR
Intervention: Music Listening (ML)
Number of subjects: 37
Study: 34498590

Group type: EXPERIMENTAL
Intervention: Heparin
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Chronic anticoagulant therapy
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: D-dimer levels
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Direct oral anticoagulant
Number of subjects: 0
Study: 33270762

Group type: EXPERIMENTAL
Intervention: Intravenous corticosteroids
Number of subjects: 7158
Study: 35395697

Group type: EXPERIMENTAL
Intervention: DWP16001 (0.2, 0.5, 1.0, 2.0 or 5.0 mg single dose)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: DWP16001 (0.1, 0.3, 0.5, 1.0 or 2.0 mg once daily for 15 days)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: DWP16001
Number of subjects: 12

Group type: COMPARATOR
Intervention: Dapagliflozin 10 mg
Number of subjects: 12

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study: 33865494

Group type: EXPERIMENTAL
Intervention: 7-day infusion set replacement
Number of subjects: 2944

Group type: COMPARATOR
Intervention: 4-day infusion set replacement
Number of subjects: 2944
Study: 34409492

Group type: EXPERIMENTAL
Intervention: Three doses of tranexamic acid (TXA) at incision, three hours post-operatively, and six hours post-operatively
Number of subjects: 99

Group type: COMPARATOR
Intervention: Single dose of tranexamic acid (TXA)
Number of subjects: 99

Group type: EXPERIMENTAL
Intervention: Three doses of tranexamic acid (TXA)
Number of subjects: 99
Study: 32335287

Group type: EXPERIMENTAL
Intervention: Isradipine
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 34260036

Group type: EXPERIMENTAL
Intervention: 300 mg/day of magnesium citrate
Number of subjects: 49

Group type: COMPARATOR
Intervention: Placebo (one sachet/day)
Number of subjects: 49
Study: 33682553

Group type: EXPERIMENTAL
Intervention: WALK-plus
Number of subjects: 40

Group type: COMPARATOR
Intervention: WALK-regular
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: WALK program (both groups)
Number of subjects: 40
Study: 32646498

Group type: EXPERIMENTAL
Intervention: Tofogliflozin
Number of subjects: 340

Group type: COMPARATOR
Intervention: Conventional treatment (control)
Number of subjects: 340
Study: 33636823

Group type: EXPERIMENTAL
Intervention: G6PD activity cutoff <7.85 U/g hemoglobin (Hb) for males
Number of subjects: 95

Group type: EXPERIMENTAL
Intervention: G6PD activity cutoff <8.95 U/g Hb for females
Number of subjects: 95
Study: 35248257

Group type: EXPERIMENTAL
Intervention: Electrolyphysis plus Aerobic Exercise (gEEA)
Number of subjects: 34

Group type: COMPARATOR
Intervention: Aerobic Exercise group (gEA)
Number of subjects: 34
Study: 34053746

Group type: EXPERIMENTAL
Intervention: Levonorgestrel intrauterine device
Number of subjects: 0
Study: 33725780

Group type: EXPERIMENTAL
Intervention: Durvalumab and Anlotinib
Number of subjects: 1

Group type: COMPARATOR
Intervention: Durvalumab (maintenance therapy)
Number of subjects: 1
Study: 33374147

Group type: EXPERIMENTAL
Intervention: Capsaicin analogue (Capsiate) 24 mg (two doses of 12 mg each)
Number of subjects: 21

Group type: COMPARATOR
Intervention: Placebo (PLA)
Number of subjects: 21
Study: 35852458

Group type: EXPERIMENTAL
Intervention: Solution of 888 mg L-1 GABA
Number of subjects: 11

Group type: EXPERIMENTAL
Intervention: Pureed fresh tomatoes
Number of subjects: 11

Group type: COMPARATOR
Intervention: Plain water (control)
Number of subjects: 11

Group type: EXPERIMENTAL
Intervention: Solution of 3673 mg L-1 glutamate
Number of subjects: 11
Study: 33682603

Group type: COMPARATOR
Intervention: Placebo group in RCTs
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: SARS-CoV-2 vaccines
Number of subjects: 0
Study: 36085810

Group type: EXPERIMENTAL
Intervention: Clinical Decision Support System (CDSS) model for predicting optimal therapeutic intervention for tinnitus patients
Number of subjects: 0
Study: 32299898

Group type: EXPERIMENTAL
Intervention: Autonomy support group (ASG)
Number of subjects: 364

Group type: EXPERIMENTAL
Intervention: Social support group (SSG)
Number of subjects: 364

Group type: COMPARATOR
Intervention: Usual care group (UCG)
Number of subjects: 364
Study: 35992551

Group type: EXPERIMENTAL
Intervention: Hospice nurse mediated aromatherapy for 28 days
Number of subjects: 60

Group type: COMPARATOR
Intervention: Regular treatment and regular nursing for advanced cancer patients
Number of subjects: 60
Study: 34851250

Group type: EXPERIMENTAL
Intervention: Active ultrasound‐guided TAP (US‐TAP)
Number of subjects: 360

Group type: COMPARATOR
Intervention: Placebo laparoscopic assisted TAP (L‐TAP)
Number of subjects: 360

Group type: COMPARATOR
Intervention: Placebo US‐TAP
Number of subjects: 360

Group type: EXPERIMENTAL
Intervention: Active L‐TAP
Number of subjects: 360
Study: 35481415

Group type: EXPERIMENTAL
Intervention: Transcutaneous electrical nerve stimulation (TENS)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Routine hospital care (Control Group)
Number of subjects: 50
Study: 33415862

Group type: EXPERIMENTAL
Intervention: Auricular pressing combined with epidural labor analgesia
Number of subjects: 180

Group type: COMPARATOR
Intervention: Epidural labor analgesia
Number of subjects: 180
Study: 36501071

Group type: EXPERIMENTAL
Intervention: Relaxation group (RG) - meditation recording during breastfeeding
Number of subjects: 72

Group type: COMPARATOR
Intervention: Control group (CG) - no intervention
Number of subjects: 72
Study: 32509293

Group type: EXPERIMENTAL
Intervention: mHealth-enhanced iCCM supportive supervision and supply chain management
Number of subjects: 3690

Group type: COMPARATOR
Intervention: iCCM as per current Zambian guidelines (Control)
Number of subjects: 3690

Group type: EXPERIMENTAL
Intervention: mHealth-enhanced iCCM
Number of subjects: 3690
Study: 34267301

Group type: EXPERIMENTAL
Intervention: Acceleromyography at the trapezius (group T; n=25)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Acceleromyography at the adductor pollicis (group A; n=25)
Number of subjects: 50
Study: 33534510

Group type: EXPERIMENTAL
Intervention: Elevation Training Mask (ETM) during low-intensity cycling exercise
Number of subjects: 16

Group type: COMPARATOR
Intervention: Control condition (no ETM) during low-intensity cycling exercise
Number of subjects: 16
Study: 32186683

Group type: EXPERIMENTAL
Intervention: Robotic transabdominal preperitoneal repair
Number of subjects: 102

Group type: COMPARATOR
Intervention: Laparoscopic transabdominal preperitoneal repair
Number of subjects: 102
Study: 36485155

Group type: EXPERIMENTAL
Intervention: stilbesterol
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: ephedrine or etilefrine
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: sildenafil
Number of subjects: 0

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: open-label, single-arm intervention
Number of subjects: 0
Study: 32826442

Group type: EXPERIMENTAL
Intervention: FCO2 laser (started 3 weeks postoperatively)
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: FCO2 laser (started 3 months postoperatively)
Number of subjects: 120

Group type: COMPARATOR
Intervention: Local creams (control group)
Number of subjects: 120
Study: 35353933

Group type: EXPERIMENTAL
Intervention: Watertight multilayer repair
Number of subjects: 21

Group type: COMPARATOR
Intervention: Non-watertight multilayer repair
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: High quality score (≥2/3)
Number of subjects: 21
Study: 33208640

Group type: EXPERIMENTAL
Intervention: Stemless implant
Number of subjects: 265

Group type: COMPARATOR
Intervention: Stemmed implant
Number of subjects: 265
Study: 36280812

Group type: EXPERIMENTAL
Intervention: Intensive training (IT) group received an additional 8-hour training.
Number of subjects: 21

Group type: COMPARATOR
Intervention: Standard training (ST) group received standard fellowship education.
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: Both groups (ST and IT) showed significant improvement in test scores post-intervention.
Number of subjects: 21
Study: 34676616

Group type: EXPERIMENTAL
Intervention: 30Pre - 30 min of resistance exercises (30% of 1RM) before a high carbohydrate meal
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: IP - 30 min of resistance exercises (30% of 1RM) immediately following a high carbohydrate meal
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: 30Post - 30 min of resistance exercises (30% of 1RM) after a high carbohydrate meal
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: 60Post - 30 min of resistance exercises (30% of 1RM) 60 min after a high carbohydrate meal
Number of subjects: 0

Group type: COMPARATOR
Intervention: C - control, high carbohydrate meal/no exercise
Number of subjects: 0
Study: 32560734

Group type: EXPERIMENTAL
Intervention: Dingkun pill (DKP)
Number of subjects: 460

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 460
Study: 34112513

Group type: EXPERIMENTAL
Intervention: Veliparib added to carboplatin-paclitaxel (6 cycles) and continued as maintenance (30 additional cycles)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control arm (carboplatin-paclitaxel only)
Number of subjects: 0
Study: 32472628

Group type: EXPERIMENTAL
Intervention: Remote ischemic conditioning (RIC)
Number of subjects: 49

Group type: COMPARATOR
Intervention: Sham-RIC (Control)
Number of subjects: 49
Study: 34583694

Group type: EXPERIMENTAL
Intervention: Individual-based oral hygiene intervention
Number of subjects: 331

Group type: EXPERIMENTAL
Intervention: Community-based intervention
Number of subjects: 331

Group type: COMPARATOR
Intervention: Both interventions
Number of subjects: 331
Study: 35039035

Group type: EXPERIMENTAL
Intervention: Recaticimab (75 mg every 4 weeks, 150 mg every 8 weeks, 300 mg every 12 weeks, 150 mg every 4 weeks, 300 mg every 8 weeks, 450 mg every 12 weeks)
Number of subjects: 110

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 110
Study: 33759183

Group type: EXPERIMENTAL
Intervention: Imagined teaching
Number of subjects: 597

Group type: EXPERIMENTAL
Intervention: Peer teaching
Number of subjects: 597

Group type: COMPARATOR
Intervention: No teaching
Number of subjects: 597
Study: 36054766

Group type: EXPERIMENTAL
Intervention: gshCBT
Number of subjects: 140

Group type: EXPERIMENTAL
Intervention: gshBWL
Number of subjects: 140

Group type: COMPARATOR
Intervention: CON
Number of subjects: 140
Study: 34496799

Group type: EXPERIMENTAL
Intervention: Nifedipine (48-hour oral treatment)
Number of subjects: 850

Group type: COMPARATOR
Intervention: Placebo (48-hour oral treatment)
Number of subjects: 850
Study: 32963704

Group type: EXPERIMENTAL
Intervention: Dexmedetomidine (DEX) group
Number of subjects: 57

Group type: COMPARATOR
Intervention: Control (Con) group
Number of subjects: 57
Study: 35240576

Group type: EXPERIMENTAL
Intervention: Acetaminophen (20 mg·kg body mass‐1)
Number of subjects: 11

Group type: COMPARATOR
Intervention: Placebo (color-matched)
Number of subjects: 11
Study: 32003413

Group type: EXPERIMENTAL
Intervention: Physical activity plus weight loss (PA+WL; n=21)
Number of subjects: 36

Group type: COMPARATOR
Intervention: Physical activity plus successful aging health education (PA+SA; n=15)
Number of subjects: 36
Study: 35791320

Group type: EXPERIMENTAL
Intervention: CVnCoV vaccine (6 or 12 µg doses)
Number of subjects: 668

Group type: EXPERIMENTAL
Intervention: CVnCoV vaccine (two doses)
Number of subjects: 668

Group type: EXPERIMENTAL
Intervention: CVnCoV vaccine (homologous booster doses)
Number of subjects: 668

Group type: EXPERIMENTAL
Intervention: CVnCoV vaccine
Number of subjects: 668

Group type: EXPERIMENTAL
Intervention: CVnCoV vaccine (two 12 µg doses)
Number of subjects: 668
Study: 33822441

Group type: EXPERIMENTAL
Intervention: Active placebo (0.04 g/kg)
Number of subjects: 231

Group type: COMPARATOR
Intervention: Non-alcohol control (tonic)
Number of subjects: 231

Group type: EXPERIMENTAL
Intervention: Alcohol (males: 0.80 g/kg; females: 0.72 g/kg)
Number of subjects: 231
Study: 36370066

Group type: COMPARATOR
Intervention: Sevoflurane
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Propofol
Number of subjects: 60
Study: 33909607

Group type: EXPERIMENTAL
Intervention: Primary care‐based integrated mobile health intervention (SINEMA intervention)
Number of subjects: 1299
Study: 35552093

Group type: EXPERIMENTAL
Intervention: Caffeine (CAF), 5mg•kg‐1
Number of subjects: 34

Group type: COMPARATOR
Intervention: Placebo (PLA), maltodextrin
Number of subjects: 34

Group type: EXPERIMENTAL
Intervention: Caffeine (CAF) for TT genotype
Number of subjects: 34

Group type: EXPERIMENTAL
Intervention: Caffeine (CAF) and DRD2
Number of subjects: 34
Study: 36364823

Group type: EXPERIMENTAL
Intervention: Telemonitoring-supported intervention (counselling in nutrition and physical activity)
Number of subjects: 302

Group type: COMPARATOR
Intervention: Wait-list control (delayed start of the same intervention)
Number of subjects: 302
Study: 32716713

Group type: EXPERIMENTAL
Intervention: Population-based screening for atrial fibrillation
Number of subjects: 0
Study: 35260961

Group type: EXPERIMENTAL
Intervention: Navigator intervention
Number of subjects: 1029

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 1029
Study: 35943749

Group type: EXPERIMENTAL
Intervention: Suction catheter-guided PLMA insertion (Group SC)
Number of subjects: 160

Group type: COMPARATOR
Intervention: Standard introducer tool-assisted technique (Group IT)
Number of subjects: 160
Study: 34175491

Group type: EXPERIMENTAL
Intervention: Randomized clinical trial (RCT)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Real-world data (RWD)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Proposed statistical framework
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Targeted maximum likelihood estimation (TMLE) method
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Integrative analysis of RCT and RWD
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Simulation results
Number of subjects: 0
Study: 32380746

Group type: EXPERIMENTAL
Intervention: 60 g/d goat cheese naturally enriched in n‐3 PUFA and CLA
Number of subjects: 68

Group type: COMPARATOR
Intervention: 60 g/d control goat cheese
Number of subjects: 68
Study: 36057968

Group type: EXPERIMENTAL
Intervention: Quitters (n=50)
Number of subjects: 176

Group type: EXPERIMENTAL
Intervention: Chewers (n=108)
Number of subjects: 176
Study: 32722083

Group type: EXPERIMENTAL
Intervention: Omega-3 enriched meat and eggs
Number of subjects: 28

Group type: COMPARATOR
Intervention: Normal chicken and eggs
Number of subjects: 28
Study: 33604731

Group type: EXPERIMENTAL
Intervention: Parent perception of child anthropometric phenotype (visual silhouette chart ranking from 1 to 7)
Number of subjects: 64
Study: 33166989

Group type: EXPERIMENTAL
Intervention: ReACH-based approach
Number of subjects: 49

Group type: EXPERIMENTAL
Intervention: ReACH principles adherence
Number of subjects: 49

Group type: EXPERIMENTAL
Intervention: Satisfaction with BodPod protocols
Number of subjects: 49

Group type: EXPERIMENTAL
Intervention: Study satisfaction
Number of subjects: 49

Group type: EXPERIMENTAL
Intervention: Qualitative feedback
Number of subjects: 49
Study: 35772045

Group type: EXPERIMENTAL
Intervention: 3 months of oxaliplatin with 6 months of fluoropyrimidine
Number of subjects: 1788

Group type: COMPARATOR
Intervention: 6 months of oxaliplatin with 6 months of fluoropyrimidine
Number of subjects: 1788

Group type: EXPERIMENTAL
Intervention: 3 months of oxaliplatin with capecitabine
Number of subjects: 1788

Group type: COMPARATOR
Intervention: 6 months of oxaliplatin with infusional fluorouracil, leucovorin
Number of subjects: 1788

Group type: COMPARATOR
Intervention: 6 months of oxaliplatin
Number of subjects: 1788
Study: 34648533

Group type: EXPERIMENTAL
Intervention: Meningococcal B vaccine (Bexsero, GlaxoSmithKline)
Number of subjects: 34489

Group type: EXPERIMENTAL
Intervention: Adjustment for social behaviours and personal characteristics
Number of subjects: 34489

Group type: EXPERIMENTAL
Intervention: Nights out socializing
Number of subjects: 34489

Group type: EXPERIMENTAL
Intervention: Smoking
Number of subjects: 34489
Study: 33159735

Group type: EXPERIMENTAL
Intervention: Muscle Energy Technique (MET)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Maitland Mobilizations
Number of subjects: 60
Study: 33802464

Group type: EXPERIMENTAL
Intervention: Perindopril
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Olmesartan
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Amlodipine
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Hydrochlorothiazide
Number of subjects: 80